National Academy of Inventors has named five University of Arizona faculty members as Class of 2024 Senior Members. To be selected as a Senior Member, academic inventors must demonstrate their rising leadership within their fields and show success in the patenting, licensing, and commercialization of innovations stemming from their work. According to the NAI, they must have produced “technologies that have brought, or aspire to bring, real impact on the welfare of society.” Continue reading
Category Archives: AZBio News
Real People – Real Stories – Vaccine Day at the Arizona State Capitol
On February 28, 2024, the Arizona Families for Vaccines held their first Vaccine Day at the Capital. Arizonans shared their personal stories of why having a well vaccinated community is important in their workplaces, in their homes, in their schools, and for their families.Continue reading
The Power of Strategic Boards in Early-Stage Bioscience Companies
Dr. Jacque Sokolov and Dr. Lishan Aklog discuss the value of forming a strategic board of directors in early-stage companies in the February 2024 AZBioPEERS webcast.Continue reading
Flinn Foundation names leadership of Arizona’s statewide bioscience committee
Higher education executive Heather Carter, UArizona biomedical engineer Jennifer Barton to serve as chair, vice chairContinue reading
Internship Opportunity: Banner-ASU Neuroscience Scholars – Apply by March 1, 2024
Spend eight weeks working side-by-side with some of the world’s most talented scientists, clinicians and researchers in an environment devoted to neuroscientific biomedical research and clinical care. Banner-ASU Neuroscience Scholars is a paid, eight-week training program open to top-achieving college undergraduate and graduate science students.Continue reading
Arizona Board of Regents paves the way for new ASU’s new medical school, M.D. degree
In a major step toward better health care for Arizonans, today the Arizona Board of Regents approved the creation of a new medical school at Arizona State University, which will open its doors to future doctors in the fall of 2026.
New research challenges conventional picture of Parkinson’s disease
Parkinson’s disease, the second most common type of progressive dementia after Alzheimer’s disease, affects nearly 1 million people in the U.S. and an estimated 10 million individuals worldwide. Each year, close to 90,000 new cases of Parkinson’s disease are diagnosed in the U.S.Continue reading
GT Medical Technologies, Inc. Names Per Langoe As CEO
Leader in Medical Technology Joins Team to Extend Reach of GammaTile® to More Patients with Brain TumorsContinue reading
Filter Study Dispels Common Myths About Valley Fever
Project in Phoenix metro area is first to look at fungus risk exposure in the airContinue reading
Avery Therapeutics, Inc. Completes In-House cGMP Manufacturing Facility Qualification
TUCSON, ARIZONA – February 13, 2024 – Avery Therapeutics, Inc. (“Avery”), a privately held, pre-clinical stage therapeutics company, proudly announces the successful qualification of their in-house cGMP pilot manufacturing facility for Phase I production in Tucson, AZ.Continue reading